Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 5 Effect of bovine anti-LOX-1 monoclonal antibody (bLOX-1 mAb), nebivolol, and its 4-keto derivative alone or in combination with bLOX-1 mAb on oxidized low-density lipoprotein (ox-LDL)-induced variations of nitric oxide (NO) in bradykinin-stimulated bovine aortic endothelial cells (BAECs). Nebivolol (25 µmol/l), its 4-keto derivative (25 µmol/l), and bLOX-1 mAb (30 µg/ml) were preincubated with BAECs for 30 min at 37°C. The cells were then stimulated with ox-LDL (50 µg protein/ml) for 10 min at 37°C. Results are expressed as mean fluorescence intensity (MFI) and are means ± SD of experiments performed in triplicate on six separate occasions. *p < 0.001 versus control; {dagger}p < 0.001 versus ox-LDL; ¶p < 0.01 versus bLOX-1 mAb.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement